A new generation of anti-obesity drugs are being hailed as game changers for the NHS and for millions of patients. So-called 'skinny jabs' like Wegovy have largely been the preserve of celebrities and those with the money to buy them privately, but now the NHS is beginning to roll them out. So will they live up to the hype, how available will they be, and is the NHS ready for a revolution in treating obesity?